Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis

International Journal of Cardiology

Volumn 195, Issue , 2015, Pages 180-187

  Yokoyama, Rami ^a   Miyagawa, Masao ^a   Okayama, Hideki ^b   Inoue, Takeshi ^b   Miki, Hitoshi ^b   Ogimoto, Akiyoshi ^a   Higaki, Jitsuo ^a   Mochizuki, Teruhito ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

18F fluorodeoxyglucose PET CT; Cardiac magnetic resonance imaging; Cardiac sarcoidosis; Myocardial fluorodeoxyglucose uptake

Indexed keywords

FLUORODEOXYGLUCOSE F 18; STEROID; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIAC IMAGING; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; STANDARDIZED UPTAKE VALUE; STEROID THERAPY; VERY ELDERLY; CARDIOMYOPATHIES; COMPUTER ASSISTED TOMOGRAPHY; DIMENSIONAL MEASUREMENT ACCURACY; HEART MUSCLE; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES;

AGED; CARDIOMYOPATHIES; DIMENSIONAL MEASUREMENT ACCURACY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; ROC CURVE; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84937611160     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.05.075     Document Type: Article

References (41)

1. K.J. Silverman, G.M. Hutchins, and B.H. Bulkley Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis Circulation 58 1978 1204 1211
2. W.C. Roberts, H.A. McAllister Jr., and V.J. Ferrans Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11) Am. J. Med. 63 1977 86 108
3. Y. Matsui, K. Iwai, T. Tachibana, and et al. Clinicopathological study of fatal myocardial sarcoidosis Ann. N. Y. Acad. Sci. 278 1976 455 469
4. K. Iwai, M. Sekiguti, Y. Hosoda, and et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy Sarcoidosis 11 1994 26 31
5. M.C. Iannuzzi, and J.R. Fontana Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics JAMA 305 2011 391 399
6. D. Mehta, S.A. Lubitz, Z. Frankel, and et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing Chest 133 2008 1426 1435
7. N.M. Gideon, and D.M. Mannino Sarcoidosis mortality in the United States, 1979-1991: an analysis of multiple-cause mortality data Am. J. Med. 100 1996 423 427
8. Diagnostic standard and guidelines for sarcoidosis Jpn. J. Sarcoidosis Granulomatous Disorders 27 2007 89 102 (in Japanese)
9. 18F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology Recommendations Ann. Nucl. Med. 28 2014 393 403
10. 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience J. Nucl. Med. 53 2012 241 248
11. 18F-fluorodeoxyglucose positron emission tomography: an autopsy case Circulation 122 2010 535 536
12. E. Tadamura, M. Yamamuro, S. Kubo, and et al. Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy Circulation 113 2006 e771 e773
13. 18FDG-positron emission tomography (PET) has a role to play in the diagnosis and therapy of infective endocarditis and cardiac device infection Int. J. Cardiol. 167 2013 1724 1736
14. R. Blankstein, M. Osborne, M. Naya, and et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis J. Am. Coll. Cardiol. 63 2014 329 336
15. C. Anagnostopoulos, A. Georgakopoulos, N. Pianou, and S.G. Nekolla Assessment of myocardial perfusion and viability by positron emission tomography Int. J. Cardiol. 167 2013 1737 1749
16. M.R. Patel, P.J. Cawley, J.F. Heitner, and et al. Detection of myocardial damage in patients with sarcoidosis Circulation 120 2009 1969 1977
17. 18F-FDG PET in identification of cardiac sarcoidosis J. Nucl. Med. 45 2004 1989 1998
18. 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur. Heart J. 26 2005 1538 1543
19. 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis Eur. J. Nucl. Med. Mol. Imaging 35 2008 933 941
20. N. Tahara, A. Tahara, Y. Nitta, and et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis J. Am. Coll. Cardiol. Img. 3 2010 1219 1228
21. Y. Nakamoto, M. Osman, C. Cohade, and et al. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images J. Nucl. Med. 43 2002 1137 1143
22. 18F-fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis Eur. J. Nucl. Med. Mol. Imaging 38 2011 1773 1783
23. 18F-FDG uptake during PET: a randomized controlled trial J. Nucl. Cardiol. 17 2010 286 291
24. 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation J. Nucl. Med. 50 2009 563 568
25. E. Persson Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin) Acta Med. Scand. Suppl. 724 1988 1 56
26. C. Salvarani, N. Pipitone, A. Versari, and et al. Positron emission tomography (PET): evaluation of chronic periaortitis Arthritis Rheum. 53 2005 298 303
27. 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis EJNMMI Res. 4 2014 1 11
28. 18F-fluorodoexyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis Eur. J. Nucl. Med. Mol. Imaging 40 2013 1558 1566
29. 18F-FDG: standardized uptake values in normal tissues J. Nucl. Med. 45 2004 784 788
30. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium Int. J. Cardiol. 169 2013 196 200
31. 18F-FDG uptake J. Nucl. Med. 48 2007 234 239
32. 18F-FDG PET-CT in the detection of cardiac sarcoidosis J. Nucl. Cardiol. 16 2009 801 810
33. 18F-fluorodoexyglucose positron emission tomography? Circ. Cardiovasc. Imaging 6 2013 617 626
34. 18F]fluoro-d-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction Mol. Imaging Biol. 4 2002 232 237
35. 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet AJR Am. J. Roentgenol. 190 2008 W151 W156
36. I. Schatka, and F.M. Bengel Advanced imaging of cardiac sarcoidosis J. Nucl. Med. 55 2014 99 106
37. Y. Yazaki, M. Isobe, M. Hiroe, and et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone Am. J. Cardiol. 88 2001 1006 1010
38. Y. Takaya, K.F. Kusano, K. Nakamura, and et al. Reduction of myocardial inflammation with steroid is not necessarily associated with improvement in left ventricular function in patients with cardiac sarcoidosis: predictors of functional improvement Int. J. Cardiol. 176 2014 522 525
39. O. Borst, M. Schaub, B. Walker, and et al. CXCL16 is a novel diagnostic marker and predictor of mortality in inflammatory cardiomyopathy and heart failure Int. J. Cardiol. 176 2014 896 903
40. J.P. Smedema, G. Snoep, M.P. van Kroonenburgh, and et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis J. Am. Coll. Cardiol. 45 2005 1683 1690
41. 18F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet J. Cardiol. 62 2013 314 319